Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Manyu, Dai"'
Publikováno v:
Pharmaceutical Biology, Vol 60, Iss 1, Pp 38-45 (2022)
Context Ferroptosis was described as an important contributor to the myocardial ischaemia/reperfusion (MIR) injury, and britanin (Bri) was reported to exert antitumor and anti-inflammatory activities. Objective Our study explores the effect and mecha
Externí odkaz:
https://doaj.org/article/266ab82e0a7545abb409d96536db1577
Autor:
Haoyang Lu, Wen Ding, Hui Xiao, Manyu Dai, Yangcheng Xue, Zhuoran Jia, Jie Guo, Mengzuo Wu, Bing Shen, Ren Zhao
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Dysfunction of potassium voltage-gated channel subfamily Q member 1 (KCNQ1) is a primary cause of long QT syndrome type 1 (LQT1). Here, we report a missense mutation P441L in KCNQ1 C-terminus of a 37-year-old woman with severe LQT1 phenotype. Variant
Externí odkaz:
https://doaj.org/article/822d77695b2241489d1aba6d419a3bb7
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Bivalirudin is a direct thrombin inhibitor (DTI) that can be an alternative to unfractionated heparin (UFH). The efficacy and safety of bivalirudin in anticoagulation therapy in extracorporeal membrane oxygenation (ECMO) remain unknown.Me
Externí odkaz:
https://doaj.org/article/baf174034aaa4f07b264cd56367bd63c
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 33:234-244
High-salt diet has been suggested to increase the risk of heart disease. However, the mechanisms underlying coronary artery tension dysfunction caused by high-salt diet are unclear. Previous studies have shown that coronary artery spasm is often indu
Publikováno v:
Pharmaceutical Biology, Vol 60, Iss 1, Pp 38-45 (2022)
Pharmaceutical Biology
article-version (VoR) Version of Record
Pharmaceutical Biology
article-version (VoR) Version of Record
Context Ferroptosis was described as an important contributor to the myocardial ischaemia/reperfusion (MIR) injury, and britanin (Bri) was reported to exert antitumor and anti-inflammatory activities. Objective Our study explores the effect and mecha
Publikováno v:
Frontiers in pharmacology. 13
Background: Bivalirudin is a direct thrombin inhibitor (DTI) that can be an alternative to unfractionated heparin (UFH). The efficacy and safety of bivalirudin in anticoagulation therapy in extracorporeal membrane oxygenation (ECMO) remain unknown.Me